Sepil Plus

Buenos International Private Limited, a leading pharmaceutical manufacturer in India, proudly announces the launch of Sepil Plus, an innovative and highly effective medicine for the treatment of diabetic wound infections, non-healing ulcers, burns, and various types of infective, traumatic, acute, or chronic wounds. Sepil Plus is also highly effective against venous and arterio-venous ulcers.

Sepil Plus is available in an oil formulation, uniquely designed to combat infections caused by both Gram-positive and Gram-negative organisms. Its efficacy extends to critical priority pathogens listed by the World Health Organization (WHO), including Acinetobacter, Pseudomonas, and MRSA.

Sepil Plus represents a significant advancement in wound care, offering a comprehensive solution for patients and healthcare providers. Its multifaceted benefits ensure enhanced healing, reduced infection risk, and improved patient comfort without the drawbacks associated with conventional treatments. With Sepil Plus, Buenos International Private Limited continues its commitment to innovation and excellence in pharmaceutical care.